Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled trial of cariprazine hydrochloride capsules in adults with schizophrenia
CTR20251045Phase 3Active
- Sponsor
- Wuhan Humanwell Pharmaceutical
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Wuhan Humanwell Pharmaceutical. Started Aug 2025; status: active.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20251045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251045.